HEALTHJun 8 · 02:11 UTCNIKKEI ASIA

Japan risks losing out without drug pricing reform, warns AstraZeneca CEO

AstraZeneca's CEO warns that Japan risks falling behind without drug pricing reform. The warning highlights potential consequences for Japan's pharmaceutical market and competitiveness.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

AstraZenecaorganizationAstraZeneca CEOpersonJapanplacedrug pricing reformtopic

Spot something wrong with this article?Report a problem →

Forward this